Related Experiment Videos
[Infections in heart transplantations]
Recenti Progressi in Medicina
|October 1, 1994
Summary
Heart transplant recipients face significant infection risks, causing substantial mortality. Prophylaxis against Cytomegalovirus (CMV) and Toxoplasma is recommended for seronegative patients to reduce infection rates.
Area of Science:
- Infectious Diseases
- Transplantation Immunology
- Cardiology
Background:
- Infections are a leading cause of mortality in heart transplant recipients, accounting for half of deaths within the first year and one-third thereafter.
- Factors contributing to post-transplant infections include underlying medical conditions, impaired immunity, prior colonization, and immunosuppression to prevent rejection or manage Cytomegalovirus (CMV) infection.
Purpose of the Study:
- To outline the spectrum of infections following heart transplantation.
- To identify the common pathogens and their temporal distribution after heart transplantation.
- To highlight the importance of prophylaxis for specific infections.
Main Methods:
- Review of infection patterns in heart transplant recipients.
- Analysis of microbial causes and timing of infections.
- Evaluation of risk factors and preventive strategies.
Main Results:
- Lung infections are most common.
- Early infections (first month) involve staphylococci, gram-negative bacteria, and herpes simplex virus reactivation.
- Mid-term infections (2-6 months) are frequently due to Cytomegalovirus (CMV) and Toxoplasma, with Pneumocystis and fungal infections also occurring.
- Late infections (>6 months) include common community-acquired infections, often more severe due to immunosuppression, and cryptococcal meningitis.
Conclusions:
- Infections pose a major threat to heart transplant recipients' survival.
- Understanding the temporal pattern of infections is crucial for timely diagnosis and management.
- Prophylaxis against Cytomegalovirus (CMV) and Toxoplasma is essential for seronegative recipients to mitigate infection risk.